WASHINGTON, Oct. 13, 2022 (GLOBE NEWSWIRE) -- According to Vantage Market Research's recent analysis of the Automated Immunoassay Analyzers Market, the increasing unhealthy lifestyle and chronic diseases such as cancer, stroke, arthritis heart disease, and diabetes propelling the growth of the market. Additionally, the rising investment in Research and Development (R&D) organizations for testing, and developing facilities for automated immunoassay analyzers. These are some of the growth factors which are likely to generate revenue for the automated immunoassay analyzers industry in the coming years.
The Qualitative research report has been prepared through in-depth secondary research, with the defined historic year and the base year, assessments and calculations are performed and the research report is delivered with the promise made to the reader's needs.
The global market was valued at USD 10.13 Billion in 2021, and according to Vantage expert analysis, the air quality control systems market size is expected to reach over USD 28.15 billion by 2028, exhibiting a CAGR of 15.6% during the forecast period. Vantage Market Research explores these insights in an Automated Immunoassay Analyzers Market Forecast Research Report 2022 to 2028.
Get Access to the In-depth Free Sample Report @ https://www.vantagemarketresearch.com/automated-immunoassay-analyzers-market-1314/request-sample
Automated Immunoassay Analyzers Market Top Companies Profiles:
- Abbott Diagnostics (US)
- Biokit (Spain)
- Biomerieux (France)
- Luminex Corporation (US)
- Roche Diagnostics (Switzerland)
- Siemens Healthcare (Germany)
Key Insights and Findings from the In-depth Report:
- The global automated immunoassay analyzers market was valued at USD 10.13 billion in 2021 and is all set to surpass USD 28.15 billion by 2028, exhibiting a CAGR of 15.6% during the forecast period 2022-2028.
- According to Vantage, research experts study, around 30 million US populations are facing heart diseases every year and 45% of them result in fatality.
- The increasing cost and lower testing facilities are likely to hinder the automated immunoassay analyzers industry.
- North America accounts for the lion's share of the automated immunoassay analyzers industry in 2021 and is projected to continue its position over the forecast period. The growth is attributed due to the significant demand for automated immunoassay analyzers in several industries and the high adoption rate owing to government measures that stimulate this industry in this region.
Market Dynamics and Growth Drivers:
Number of Population Suffering from Chronic Diseases to Drive Market Growth
An increasing number of people facing critical conditions have started requiring automated immunoassay analyzer testing facilities. This technique is considered to have a moderate risk of complications and hence proves to be a good solution compared to others. Cities are witnessing outbreaks of various diseases as a result of the increasing population and modern lifestyle. The majority of the population is suffering from diseases like diabetes, heart disease, cancer, and others. According to Vantage, research experts study, around 30 million US populations are facing heart diseases every year and 45% of them result in fatality.
The demand for automated immunoassay analyzers in laboratories and hospitals has increased recently, as they ensure the accuracy of reports and at the same time make laboratory processes more efficient. The high sensitivity of automated immunoassay analyzers makes them a perfect asset for medical personnel in these difficult times, as these devices can help accurately detect infected populations.
Limited Time Offer | Buy this Premium Research Report with Exclusive Discount and Immediate Delivery@ https://www.vantagemarketresearch.com/buy-now/automated-immunoassay-analyzers-market-1314/0
The Increasing Cost and Lower Testing Facilities are Likely to hinder the Automated Immunoassay Analyzers Market
Automated immunoassay analyzer testing for the diagnosis of neurological, cardiovascular, rheumatic, and other diseases is an area of interest. The major disadvantages of the automated immunoassay analyzer are its high cost and low availability in healthcare facilities. The cost of automated immunoassay analyzers is high due to the management of the patient hospital setting, infrastructure, and risk analysis. This makes them expensive and hence may hinder the growth of the automated immunoassay analyzers market to some extent.
Important questions answered in this report:
- What is the estimated market size and growth rate of the Automated Immunoassay Analyzers Market?
- Which segments are included in the Automated Immunoassay Analyzers Market?
- Which top companies are active in the Automated Immunoassay Analyzers Market?
- What are the major driving factors for the growth of the Automated Immunoassay Analyzers Market?
- How can I get free sample reports or study of Automated Immunoassay Analyzers Market?
Browse market data Tables and Figures spread through 156 Pages and in-depth TOC on Automated Immunoassay Analyzers Market Forecast Report (2022-2028).
Scope of the Report:
| Report Attributes | Details |
| Market Size in 2021 | USD 10.13 Billion |
| Revenue Forecast by 2028 | USD 28.15 Billion |
| CAGR | 15.6% from 2022 to 2028 |
| Base Year | 2021 |
| Forecast Year | 2022 to 2028 |
| Key Players |
|
The Report on the Automated Immunoassay Analyzers Market highlights:
- Assessment of the market
- Premium Insights into Industry
- In-depth Competitive Landscape
- COVID Impact Analysis
- Historical Data, Current Data, and Forecast Data
- Top and Emerging Company Profiles
- Global and Regional Dynamics
Ask for Customization: https://www.vantagemarketresearch.com/automated-immunoassay-analyzers-market-1314/customization-request
Regional Analysis:
North America to Witness Rapid Growth
North America accounted for the highest revenue share of the total market due to the high adoption of automated immunoassay analyzers and the rise in the adoption of advanced healthcare technology products. This is a major factor driving the forecast growth of the Automated Immunoassay Analyzers market in this region. Furthermore, many patients in this field are leaning towards adopting Automated Immunoassay Analyzer test results and helping them to diagnose faster.
The Asia Pacific is all set to grow at a faster rate during the forecast period due to an increase in the number of well-established automated immunoassay analytical facilities. The region is home to major research institutes and research and development (R&D) facilities that are fuelling the growth of the market. Some of the factors expected to contribute to the growth of this market are a large number of ongoing research studies and the growth of the overall healthcare sector globally.
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us at sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Browse More Research Topics on Healthcare Related Reports:
- Mammography Market was valued USD 1.8 Billion in 2021 and is anticipated to reach a value of USD 3.2 Billion by 2028: https://www.vantagemarketresearch.com/industry-report/mammography-market-1850
- Breast Reconstruction Market was valued at USD 562.9 Million in the year 2021 and is projected to reach a value of USD 652.7 Million by the year 2028: https://www.vantagemarketresearch.com/industry-report/breast-reconstruction-market-1714
- Smart Insulin Pens Market was valued USD 92.1 Million in 2021 and is anticipated to reach a value of USD 180.8 Million by 2028: https://www.vantagemarketresearch.com/industry-report/smart-insulin-pens-market-1830
- Hearing Aids Market was valued at USD 9.9 Billion in the year 2021 and is forecast to reach a value of USD 13.0 Billion by the year 2028: https://www.vantagemarketresearch.com/industry-report/hearing-aids-market-1785
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
Follow Us on Facebook: https://www.facebook.com/vantagemarketresearch
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: sales@vantagemarketresearch.com
Website: https://www.vantagemarketresearch.com/
Latest Vantage Market Research Press Releases @https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
Blog:
- https://bwsc.kr/
- https://makitirapide.com/
- https://marketstrades.com/
- https://v-mr.biz/
- https://techwire24.com/
- https://eurooo.fr/
- https://basital.de/
- https://emarketbee.com/
- http://globalresearchwire.com/
- https://www.ourdia-medium.fr/
- https://www.ecofege.fr/
